Keyphrases
Psoriatic Arthritis
100%
Randomized Controlled Clinical Trial
100%
Meta-analysis
100%
Systematic Meta-analysis
100%
Placebo
100%
T Helper 17 (Th17)
100%
Relative Risk
75%
Treatment Discontinuation
50%
Infection Risk
50%
TNF-α Antagonists
50%
Placebo-controlled
50%
Serious Adverse Events
50%
Randomized Controlled Trial
50%
Cochrane
25%
Joint Disease
25%
Short-term Treatment
25%
Active Control
25%
Adverse Events
25%
Clinically Meaningful Improvement
25%
Disease Activity
25%
Serious Infection
25%
ACR50
25%
Tuberculosis
25%
American College of Rheumatology
25%
Risk of Bias Tool
25%
Disabling Conditions
25%
Increased Incidence
25%
Mechanism of Action
25%
Candida Infection
25%
Incident Cases
25%
Biological Agents
25%
Quality Assessment
25%
Pathway Inhibitors
25%
Random Effects Model
25%
Overall Treatment Effect
25%
Acceptable Safety
25%
Scopus
25%
Tolerability
25%
Publication Bias
25%
Objective Risk
25%
ACR20
25%
Pharmacology, Toxicology and Pharmaceutical Science
Controlled Clinical Trial
100%
Placebo
100%
Psoriatic Arthritis
100%
Tumor Necrosis Factor
50%
Biological Product
50%
Infection
50%
Adverse Event
50%
Randomized Controlled Trial
33%
Arthropathy
16%
Candidiasis
16%
Diseases
16%
Random Effects Model
16%
Tolerability
16%
Disease Activity
16%